Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

DePuy AcroMed licenses BMP technology from Biopharm

Executive Summary

Biopharm GMBH (drug discovery for orthopedics and neurodegenerative diseases) has licensed DePuy AcroMed (Johnson & Johnson's orthopedic devices and implants division) exclusive worldwide rights to its MP52-based bone morphogenic protein (BMP) compounds and technology portfolio to develop products for bone, cartilage, and soft tissue repair.
Deal Industry
  • Pharmaceuticals
  • Medical Devices
    • Biomaterials
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies